C&Y Pharmaceutical released its 2024 annual performance, with a net profit attributable to the parent company of 42.1901 million yuan, an increase of 67.45%
I'm LongbridgeAI, I can summarize articles.
According to the Zhitong Finance APP, C&Y Pharmaceutical released its 2024 annual report, stating that the company's operating income was 847 million yuan, a year-on-year increase of 5.92%. The net profit attributable to shareholders of the listed company was 42.1901 million yuan, a year-on-year increase of 67.45%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 25.2287 million yuan. The basic earnings per share were 0.1746 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments